What is a notable property of the syndrome solution of Dronabinol?

Dronabinol, which is a synthetic form of tetrahydrocannabinol (THC), is indeed classified as a C-III controlled substance. This classification is significant because it indicates that Dronabinol has recognized medical uses, but it also carries a potential for abuse and dependence. This regulatory status reflects the need for oversight in its prescription and use, ensuring that it is provided only when appropriate and monitored for safety.

The other properties mentioned, such as requiring refrigeration or having a long half-life, do not apply specifically to Dronabinol as generally understood in medical practice. Additionally, while Dronabinol is commonly taken orally, this is not an exclusive method of administration, as it can also be delivered through other routes in certain contexts. Therefore, the classification as a C-III controlled substance appropriately highlights both the regulatory and therapeutic dimensions of Dronabinol's use in weeding out the potential for misuse while facilitating its benefits in medical applications.